透過您的圖書館登入
IP:3.17.179.239
  • 期刊

The nNOS/cGMP Mediation of the Depressor Response to NMDA Receptor Stimulation in the Caudal Ventrolateral Medulla

並列摘要


Using in vivo voltammetry to directly measure extracellular nitric oxide (NO) levels, our previous studies suggested that the neuronal NO synthase (nNOS) and cyclic guanosine monophosphate (cGMP) signal transducing systems are involved in the cardiovascular responses elicited by activation of Nmethyl- D-aspartate (NMDA) receptors in the rostral ventrolateral medulla. In this study, we examined if the depressor responses elicited by activation of NMDA receptors in the caudal ventrolateral medulla (CVLM) also depend on the actions of nNOS and soluble guanylyl cyclase. In anesthetized cats, microinjection of NMDA into the CVLM produced hypotension and bradycardia associated with NO formation. These NMDA-induced responses were attenuated by prior injections of 2-amino-5-phosphonopentanoate (a NMDA receptor competitive antagonist), 7-nitroindazole (a nNOS inhibitor) and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (an inhibitor of soluble guanylyl cyclase). These findings suggest that NO is also involved in the NMDA-induced depressor responses of the CVLM.

參考文獻


Aoki, C.,Rhee, J.,Lubin, M.,Dawson, T.M.(1997).NMDA-R1 subunit of the cerebral cortex co-localizes with neuronal nitric oxide synthase at pre-and postsynaptic sites and spines.Brain Res.750,25-40.
Calver, A.,Collier, J.,Vallance, P.(1993).Nitric oxide and cardiovascular control.Exp. Physiol.78,303-326.
Dampney, R.A.L.(1994).Functional organization of central pathways regulating the cardiovascular system.Physiol. Rev.74,323-364.
Fedele, E.,Raiteri, M.(1996).Desensitization of AMPA receptors and AMPA-NMDA receptor interaction:an in vivo cyclic GMP microdialysis study in rat cerebellum.Br. J. Pharmacol.117,1133-1138.
Feelisch, M.(1991).The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions.J. Cardiovasc. Pharmacol.17,25-33.

延伸閱讀